We reported a downregulation trend of the expression of most analyzed enzymes, as well as significant decrease in protein abundance of CYP1A1, CYP1A2, CYP2C8, CYP2C9, CYP3A4 and CYP3A5 in WD patients. This evidence concerns the gene CYP1A1 and Wilson disease.